NCT05149339View on ClinicalTrials.gov

Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

March 1, 2019

Primary Completion Date

February 1, 2020

Study Completion Date

March 15, 2021

Conditions
Acute Myeloid LeukemiaVitamin D DeficiencyADAMTS13Interleukin 6
Interventions
DRUG

Cholecalciferol 2800 I.U. ml oral drops

"(Cholecalciferol 2800 I.U. ml) Oral Drops 15 ml. supplied with a dropper.~* Composition:~Each 1 ml (= 28 drops) of oral solution contains: Vitamin D3 (Cholecalciferol) 2800 I.U., (each drop contains 100 IU of vitamin D3)."

Trial Locations (1)

19519

Dina Ashraf Abdelhady, Cairo

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT05149339 - Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia | Biotech Hunter | Biotech Hunter